Moreover, in vivo silencing of galectin-1 in Hs683 orthotopic xenografts significantly decreased vessel density of tumors, suggesting that galectin-1 is a central player in glioma angiogenesis. The gene discussed is LGALS1; the disease is central nervous system cancer.